Smart for Life (SMFL) Featured by New to the Street
Interviews to Air on National Television Including Bloomberg and Fox Business
MIAMI, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Smart...
Revive Therapeutics (RVVTF) Announces Finalization of Amended Phase 3 COVID-19 Study Protocol to FDA
TORONTO, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life...
Smart For Life (SMFL) $0.37 Announces Initiation of Equity Analyst Coverage by Dawson James...
Initiates with “Buy” recommendation and $8 price target.
MIAMI, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Smart for Life,...
Mpox Vaccines and ‘Emergency Use’ Authorization Explained.
mpox Vaccine EUAs
On November 28, 2022, the World Health Organization announced, and the U.S. government supported, renaming monkeypox disease...
ARK vs. SARK
Ever get really, really bearish and really, really wish you could find a simple way to make money in a bear market?
Adding ‘Internet of Things,’ Direct Communications (DCSX) $1.17 to the Watch List.
Chris Bursey, Member of Verizon's Internet of Things (IOT) Advisory Council, Charges Ahead as CEO of Direct Communication (DCSX).
Smart for Life (SMFL) Announces Letter of Intent to Acquire Largest Acquisition to Date.
6th Acquisition to Date is Expected to Add over $15 million of Revenue and to be Accretive to Earnings.
Revive (RVVTF) Hits a Snag?
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
First our summary."FDA provided communication that...
Revive Therapeutics (RVVTF) Annual Shareholder Meeting.
ANNUAL SHAREHOLDER MEETING
https://vimeo.com/752050831
Nu-Med Plus (NUMD) on the Tape.
MicroCap Daily
LIVE QUOTE
Nu-Med Plus Inc (OTCMKTS: NUMD) is...
Latest article
Epidemic Denial: RFK Jr. Holds Press Conference on new Autism findings from the CDC
Health and Human Services Secretary Robert F. Kennedy Jr. will be joined by officials on Wednesday to discuss the latest Autism and...
GeoVax (GOVX) Down on JFK’s Continued Scale Backs to the Vaccine Sector.
Down 20% in response to news in an 8K that the Biomedical Advanced Research and Development Authority BARDA (also once known as the...
Adding Allarity (ALLR) $0.70, to Watch List.
LIVE QUOTE
SHORT TERM CHART
Bargain Hunting?
Adding to the...
